nps-568 has been researched along with calcium gluconate in 2 studies
| Studies (nps-568) | Trials (nps-568) | Recent Studies (post-2010) (nps-568) | Studies (calcium gluconate) | Trials (calcium gluconate) | Recent Studies (post-2010) (calcium gluconate) |
|---|---|---|---|---|---|
| 162 | 4 | 54 | 1,169 | 76 | 256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conklin, RL; Fox, J; Lowe, SH; Nemeth, EF; Petty, BA | 1 |
| Torres, VE | 1 |
2 other study(ies) available for nps-568 and calcium gluconate
| Article | Year |
|---|---|
Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca(2+) receptor in rats.
Topics: Aniline Compounds; Animals; Calcitonin; Calcium; Calcium Gluconate; Calcium-Binding Proteins; Dose-Response Relationship, Drug; Hypocalcemia; Kinetics; Male; Parathyroid Glands; Parathyroidectomy; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Thyroidectomy | 1999 |
Type II calcimimetics and polycystic kidney disease: unanswered questions.
Topics: Aniline Compounds; Animals; Calcium; Calcium Gluconate; Disease Models, Animal; Disease Progression; Male; Phenethylamines; Polycystic Kidney Diseases; Propylamines; Rats | 2009 |